Medline Inc.
MDLN
$34.05
-$0.64-1.85%
NASDAQ
| 06/27/2026 | 03/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.53% | -5.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.53% | -5.59% | |||
| Cost of Revenue | -0.74% | -6.16% | |||
| Gross Profit | 20.32% | -3.81% | |||
| SG&A Expenses | 5.46% | -2.92% | |||
| Depreciation & Amortization | 0.57% | 0.00% | |||
| Other Operating Expenses | 2,220.00% | -50.00% | |||
| Total Operating Expenses | 5.19% | -5.64% | |||
| Operating Income | -6.40% | -4.74% | |||
| Income Before Tax | -19.24% | 41.26% | |||
| Income Tax Expenses | 84.62% | 100.00% | |||
| Earnings from Continuing Operations | -41.84% | 32.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 28.18% | -5,600.00% | |||
| Net Income | -53.49% | -29.12% | |||
| EBIT | -6.40% | -4.74% | |||
| EBITDA | -3.70% | -3.98% | |||
| EPS Basic | -59.06% | -25.10% | |||
| Normalized Basic EPS | -9.69% | -59.29% | |||
| EPS Diluted | -57.47% | -27.90% | |||
| Normalized Diluted EPS | -9.53% | -59.56% | |||
| Average Basic Shares Outstanding | 4.48% | 1.23% | |||
| Average Diluted Shares Outstanding | 4.37% | 1.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||